Here is the original post:
Nuvectis Pharma to Present at the 36th Annual Roth Conference
New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia
Eupraxia Pharmaceuticals Announces Closing of Overnight Marketed Offering for Gross Proceeds of C$33.9 Million
Read more from the original source:
Eupraxia Pharmaceuticals Announces Closing of Overnight Marketed Offering for Gross Proceeds of C$33.9 Million
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
Here is the original post:
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
Go here to read the rest:
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.
Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement…
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
Sanofi: Information concerning the total number of voting rights and shares – February 2024
NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
Read more from the original source:
NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
Here is the original post:
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
Financière de Tubize – Annual report 2023
Originally posted here:
Financière de Tubize - Annual report 2023
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed
See the original post here:
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed